Doctors looking into hormone therapy as a way to ward off dementia in women

A new technology developed by scientists at Northwell Health enables patients with paralysis to move their limbs using neural implants. These chips facilitate a brain-computer interface that reconnects the patient's brain, body, and spinal cord, marking a significant advancement in medical technology.

The Centers for Medicare and Medicaid Services has announced a significant reduction in prices for 15 prescription drugs, including Ozempic, aimed at improving access for Medicare beneficiaries. This initiative is part of broader efforts to enhance affordability in healthcare.

Medicare has announced that starting in 2027, recipients will see reduced prices for 15 prescription drugs, including the widely used weight loss medications Ozempic and Wegovy. This initiative is projected to save taxpayers approximately $12 billion, enhancing affordability for beneficiaries.

A junior college basketball player from Oklahoma died on Tuesday after suffering a head injury during a game in Texas over the weekend, as confirmed by his school. The incident highlights the risks associated with contact sports and the potential for serious injuries that can occur during athletic competitions.

A recent study has identified five distinct 'epochs' in the human brain's development throughout a lifetime, highlighting how the brain rewires itself as individuals age. This research sheds light on the dynamic nature of brain function and structure over time.

The flu season has begun earlier than expected in several regions of the United States, raising alarms among healthcare professionals about a potential surge in cases as millions prepare to travel for Thanksgiving and other holidays. Doctors are particularly concerned about the implications of increased gatherings during this time.

Novo Nordisk's weight loss drug Wegovy has failed to demonstrate any efficacy in slowing the progression of Alzheimer's disease, according to recent trials. Initial hopes were pinned on the drug's potential to impact cognitive decline positively, but results have shown no significant benefits for patients with dementia or mild cognitive impairment.